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ABSTRACT: Alternative Splicing of messenger RNA precursors is a key process in gene regulation, contributing to the diversity 
of proteomes by the alternative selection of exonic sequences. Most cancers are associated with alterations in this mechanism, en-
hancing their proliferation and survival, and can be employed as cancer biomarkers. Label-free optical biosensors are ideal tools for 
the highly sensitive and label-free analysis of nucleic acids. However, their application for alternative splicing analysis has been 
hampered due to the formation of complex and intricate long-range base-pairing interactions which make the direct detection in 
mRNA isoforms difficult. To solve this bottleneck, we introduce a new methodology for the generation of length-controlled RNA 
fragments from purified total RNA, which can be easily detected by the biosensor. The methodology seizes RNase H enzyme activ-
ity to degrade the upstream and downstream RNA segments flanking the target sequence upon hybridization to specific DNA-
oligos. It allows the fast and direct monitoring of Fas gene alternative splicing in real-time employing a Surface Plasmon Reso-
nance (SPR) biosensor. We demonstrate the selective and specific detection of mRNA fragments in the pM-nM concentration 
range, reducing quantification errors and showing 81% accuracy when compared to RT-qPCR. The site-specific cleavage outper-
formed a random RNA hydrolysis by increasing the detection accuracy in 20%, making this methodology particularly appropriate 
for label-free quantification of alternative splicing events in complex samples. 
Gene regulation pathways play important roles in 
every process of life, including cell differentiation, metabo-
lism, cell cycle, and signal transduction. There are many regu-
latory mechanisms that serve the cells to quickly adapt to envi-
ronmental changes by modulating gene expression levels, es-
tablishing a complex and highly structured gene regulatory 
network. Alternative splicing (AS) is a key post-transcriptional 
process in the gene expression regulatory pathway. Splicing of 
precursor messenger RNA (Pre-mRNA) can generate different 
mature mRNAs that contain various combinations of exons, 
contributing to the diversity of proteomes. Alterations in AS 
processes can cause or modify the development of a variety of 
diseases including cancer1. Most cancers are associated with a 
switch in the splicing pattern of specific isoforms that provides 
them with proliferative capacity and survival properties2. In 
addition, splice variants diversify the repertoire of biomarkers 
and functionally contribute to drug resistance during chemo-
therapy3. For example, Safikhani et al. demonstrated that iso-
form analysis represents a promising brand-new class of bi-
omarkers for patient stratification in cytotoxic and targeted 
anticancer therapies4. Also, it has been demonstrated that RNA 
splicing events are crucial drivers of prostate cancer aggres-
siveness and therapeutic resistance in African American men5. 
Therefore, the evaluation of splice variants holds great prom-
ise for improving disease diagnosis and, ultimately, patient 
care in the era of precision medicine6. In fact, recent studies 
focusing on prostate cancer have demonstrated that mRNA 
analysis of circulating tumour cells could reveal substantial 
information on drug sensitivity and resistance7, which can lead 
to the development of less invasive approaches to modulate 
and monitor this process in therapeutic settings8,9.  
The knowledge of the mechanisms and dynamics of AS has 
grown substantially in recent years, confirming its critical role 
in human health and disease. The gold-standard approach to 
characterize AS is reverse transcription of mRNA followed by 
polymerase chain reaction amplification (RT-qPCR)10. Also, 
microarrays have been designed to sample AS events on a 
genome scale and successfully used to examine AS across 
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tissues, cellular states and species11,12. RNA-sequencing com-
bined with computational tools have emerged as powerful 
tools for the examination of AS at a genome-wide level, 
providing opportunities to leverage AS to advanced diagnos-
tics and prognostics tests for the delivery of effective medi-
cines to patients. Recently, label-free optical biosensors have 
been pointed out as potential solutions for disease diagnostics 
and therapy follow-up by the analysis of nucleic acids13. These 
biosensors are high-sensitive analytical devices able to per-
form label-free assays in a timely and inexpensive manner, 
with minimal operator training and easy-to-perform proce-
dures.  
The Surface Plasmon Resonance (SPR) biosensor is consid-
ered the landmark in optical biosensors. SPR sensors have 
been widely employed in the pharmaceutical industry and 
research laboratories for the study of numerous types of bio-
molecular interactions14. SPR biosensors can detect, monitor, 
and quantify molecules attaching to the sensor surface by 
measuring the change in the refractive index (RI) produced at 
its immediate vicinity, thus avoiding amplification steps or 
molecular labelling. However, the most challenging factor in 
label-free detection of mRNAs is the target length. Long sin-
gle-stranded RNA sequences are prone to generate secondary 
and tertiary structures through complex base-pairing and 
backbone interactions facilitated by the intrinsic flexibility of 
RNA moieties. These complex structures can hide the target 
sequence and hinder their accessibility to the bioreceptor 
monolayer. In addition, the production of nucleic acid se-
quences by conventional oligonucleotide synthesis processes 
has some limitation due to chemical reaction efficiency. As a 
result, the length of synthetic oligonucleotides typically do not 
exceed 150-200 nucleotides (nt)15, which impedes the pre-
calibration of the biosensor by employing standards for target 
sequences over 200 nt. This is one possible reason why there 
is a shortage of publications related to the detection of long 
RNA sequences with label-free optical biosensors13. Our team 
previously demonstrated the capabilities of an SPR biosensor 
for the label-free analysis of AS events16. In this study we 
showed that RNA fragmentation was necessary for the accu-
rate assessment of AS events by the SPR biosensor, since the 
signal from these long-sequences was almost negligible prob-
ably due to the target sequences low accessibility. To do that, 
a sample pre-processing step was applied for the fragmenta-
tion of purified total RNA. The strategy followed takes ad-
vantage of the susceptibility of phosphodiester bonds from the 
ribose sugar phosphate backbone of RNA to be hydrolysed in 
alkaline medium17, generating ~200-nt mRNA fragments, 
which can be directly analysed by the SPR biosensor without 
PCR-amplification. However, the incubation time is a crucial 
parameter in this approach since it promotes a random cleav-
age and is prone to lose sample input by disruption of the se-
quence of interest. This time will also vary depending on the 
sample quality. Poor-quality samples could be caused by RNA 
degradation. Thus, additional alkaline degradation is not ad-
visable because it can foster the loss of target input and bias 
the final biosensor readout. In such cases, it is important to 
keep RNA integrity to ensure an accurate analysis. Therefore, 
other methodologies should be considered in order to achieve 
a more controlled cleavage of RNA molecules.  
Whereas DNA molecules can be easily cut at specific se-
quence sites by restriction enzymes, there are no specific tools 
for selective RNA sequence fragmentation. This disadvantage 
makes particularly difficult to generate RNA fragments of 
interest in a controlled manner. RNase H is an enzyme known 
to specifically degrade the RNA strand of RNA-DNA hybrid 
duplexes18. For example, it has been employed in the identifi-
cation of a particular group of microbes based on the cleavage 
of a particular region in ribosomal RNAs (rRNAs)19. In this 
work, we introduce RNase H-mediated cleavage as a new 
methodology for the generation of specific RNA fragments of 
a length of interest and demonstrate its applicability for the 
real-time analysis of AS events using an SPR biosensor. The 
RNA site-specific cleavage employs two designed DNA oli-
gonucleotides complementary to the upstream and down-
stream RNA segments flanking the specific RNA sequence of 
interest (Figure 1A). These DNA oligonucleotides, once hy-
bridized to the endogenously transcribed AS isoforms, will 
promote the degradation of the hybridized RNA segment by 
RNase H activity, liberating the flanked sequence and making 
it available for its subsequent analysis by the SPR biosensor 
(Figure 1B). Compared to alkaline hydrolysis, which produces 
random RNA fragments, the RNase H method enables high 
precision fragmentation, thus ensuring that target RNA se-
quence is released intact with high selectivity and efficiency. 
Further, it offers the advantage of analysing the RNA frag-
ments of interest directly in a PCR amplification-free mode 
and without risk of sample input loss, contrary to the alkaline 
hydrolysis approach.  
The methodology is implemented for the evaluation of AS 
events in Fas gene mRNA isoforms, which play antagonistic 
roles in programmed cell death and are relevant to cancer. AS 
of Fas gene generates two isoforms depending on the inclu-
sion or skipping of its exon 6 (ie. Fas567 or Fas57, respective-
ly). Fas567 isoform encodes a full-length transmembrane pro-
tein receptor known as Fas/ CD95 that binds to Fas ligand 
(FasL), activating the signalling cascade of the extrinsic apop-
totic pathway20. Fas57 isoform lacks the trans-membrane do-
main, producing a soluble protein known as sFas that com-
petes with the Fas receptor in the extra-cellular environment 
by binding to FasL. This version of Fas is overexpressed in 
cancer cells21,22, and contributes to cancer aggressiveness23,24. 
We have optimized the RNase H cleavage conditions in terms 
of buffer composition, enzyme concentration and reaction 
temperature. Finally, the usefulness of the methodology has 
been demonstrated by the analysis of the endogenous expres-
sion of Fas gene alternative splicing isoforms in HeLa cells 
and its performance comparison with the gold-standard RT-















Figure 1. Scheme of the developed methodology. (A) RNase H specific cleavage process. (B) SPR biosensor methodology for specific 
detection of AS isoforms in HeLa cells. 
 
MATERIALS AND METHODS 
Chemical reagents and buffers. Solvents used for gold sen-
sor chip cleaning were purchased to Panreac Applichem (Bar-
celona, Spain): Acetone 99.5% and Ethanol 99%. Main salts 
and chemical reagents for sensor cleaning, buffer preparation 
and biofunctionalization were acquired from Sigma-Aldrich 
(Germany): Sodium Dodecyl Sulfate (SDS), Hydrochloric 
Acid (HCl), Sodium Phosphate monobasic (NaH2PO4) 99%, 
Sodium Phosphate dibasic (Na2HPO4) ≥99%, Sodium Chlo-
ride (NaCl) ≥99.5%, Sodium Citrate dihydrate ≥99%, 6-
Mercapto-1-hexanol (MCH) 97% and Formamide ≥99.5%.  
Several buffers and solvents have been prepared either for 
functionalization or target analysis: PBS 50 mM (50 mM 
Phosphate buffer, 0.75 mM NaCl –pH 7-), 20x SSC (3 M 
NaCl, 0.3 M sodium citrate –pH 7-), 1x Alkaline hydrolysis 
buffer (Carbonate/Bicarbonate 50mM, EDTA 1mM, pH 9.2) 
and RNA fragmentation stop solution (3M Sodium Acetate), 
RNase H buffer (50 mM Tris-HCl, 75 mM KCl, 3 mM 
MgCl2, 10 mM DTT -pH 8.3-). Buffer solutions were pre-
pared by using H2O milliQ incubated O/N with 2% DEPC and 
autoclaved at 121ºC for 1 hour. 
DNA sequences. All DNA-probes and synthetic targets were 
purchased from IBA GmbH (Goettingen, Germany) and are 
summarized in Table 1. DNA-probe sequences incorporate a 
thiol group at the 5’-end to enable chemical coupling with the 
gold sensor surface. In addition, a spacing region, which con-
sists of a 15-thymine sequence (polyT15) is placed between the 
thiol group and the matching region. This sequence will not 
participate in the hybridization event but, instead, it acts as a 
vertical spacer due to the low affinity of thymine bases for 
gold surfaces25. The length of this polyT15 has been demon-
strated to outperform the biosensor performance compared to 
other lengths 26. mRNA isoform sequences were obtained from 
Ensembl genenome browser 
(http://www.ensembl.org/index.html). DNA/RNA sequences 
employed are summarized in Table 1. 
SPR biosensor. The SPR biosensor device is based on 
Kretschmann configuration and monitors refractive index (RI) 
changes in real time27. A schematic illustration of the SPR 
biosensor is shown in the Suplementary Material (Figure S1). 
A p-polarized light of 670 nm from a laser source is divided in 
two identical beams focused on the crystal-backside of the 
gold sensor chip (glass surface coated with 2 nm of chromium 
and 45 nm of gold, 10×10×0.3mm3, SSens, Enschede, The 
Netherlands). Measurements are performed at a fixed angle of 
incidence. Variations of the RI are detected due to the bioin-
teraction events occurring at the sensor surface as changes in 
the reflected light intensity by a multielement photodiode. The 
flow system consists of two flow cells (300 nL each) for inde-
pendent analysis. The device incorporates all optics, electron-
ics and fluidics components necessary to operate autonomous-
ly. Sensograms reproduce the binding event by monitoring the 
increase (or decrease in case of unbinding events) of the inten-
sity of the reflected light (ΔReflectivity (%), ΔR (%)) vs. time 
(seconds, s). This change of the intensity of the reflected light 
is directly related to changes in the RI of the dielectric medi-
um caused by mass changes on the metallic sensor surface.  
DNA-probe immobilization. Prior to DNA-probe immobili-
zation, gold sensor chips were cleaned by consecutive soni-
cation cycles (1min) with solvents of increasing polarity (i.e. 
acetone, ethanol and dH2O) previously heated up to their boil-
ing point. Then, substrates were dried under nitrogen flux and 
placed in a UV/O3 generator (BioForce Nanosciences, USA) 
for 20 min. After that, gold sensor chips were subsequently 
rinsed with ethanol and water and dried under nitrogen flux. 
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For RNase H activity optimization, formation of a self-
assembled monolayer (SAM) of DNA1 probe was carried out 
in-situ on the gold sensor chip by flowing 250 mL of a solu-
tion containing 1 µM of DNA1 probe in 1x PB buffer solution 
at a 12 mL/ min rate. For Fas gene isoform detection, for-
mation of mixed SAMs of either Fas56-probe or Fas57-
probe/MCH (20:1, 1 µM) was carried out in-situ on the gold 
sensor chip by flowing 250 mL of the mix in 1x PB buffer 
solution at a 12 mL/ min rate. We immobilized each isoform 
probe in independent SPR channels. 
Alkaline hydrolysis of purified total RNA from HeLa cells. 
Total RNA from human cervical carcinoma HeLa cells (ap-
prox. 1.5 million cells) was isolated using the RNeasy kit (Qi-
agen, Germany).  For alkaline hydrolysis, samples were pre-
heated at 95ºC for 15 s and mixed with preheated 1xAlkaline 
hydrolysis buffer (Carbonate/Bicarbonate 50mM, EDTA 
1mM, pH 9.2) to start the hydrolysis reaction. Total RNA 
samples were exposed to the alkaline buffer for 3 minutes. 
After each incubation time, samples were placed on ice and 
reaction was stopped with RNA fragmentation stop solution 
(3M Sodium Acetate, pH 5.2). After applying the fragmenta-
tion protocol, endogenous levels of Fas isoforms were 
checked using the SPR biosensor. 
RNase H cleavage of purified total RNA from HeLa cells. 
Total RNA from human cervical carcinoma HeLa cells (aprox. 
1.5 million cells) was isolated using the RNeasy kit (Qiagen, 
Germany). They were transfected at 50% confluency with 0.4 
micrograms of Fas minigenes28 and 10 micrograms of plasmid 
DNA expressing either beta galactosidase or PTB, per culture 
plate of 10 cm. When 6-wells plates were used, 50 ng 
minigene and 3 micrograms of expression plasmid DNA were 
transfected per well. When minigene and protein expression 
vectors were used, cells were collected 48 hours post-
transfection. Total RNA was isolated using the RNeasy kit 
(Qiagen) and the pattern of alternative splicing was analyzed 
by RT-PCR. Reverse transcription was carried out using 
AMV-Reverse Transcriptase (Promega) and specific reverse 
primers28. Polymerase chain reaction was carried out using 
GoTaq (Promega) and forward and reverse primers corre-
sponding to the exonic regions flanking the alternatively 
spliced sequences29. For SPR biosensor analysis, two DNA-
oligos were designed, complementary to the sequences flank-
ing exon 5 (3’ end of exon 4) and exon 7 (5’ end of exon 8) 
(see Table 2). These sequences, once hybridized to the endog-
enously transcribed isoforms, will promote the degradation of 
the RNA sequence in contact, producing fragments of approx-
imately 200 nts (Table 2). We incubated total RNA with 10 
µM concentration of each DNA-probe at 95 ºC for 2 min and 
cooled it on ice for 5 min for probe-annealing. After anneal-
ing, RNA samples were incubated with 100 U/mL of RNase H 
in 1x RNase H buffer (50 mM Tris-HCl, 75 mM KCl, 3 mM 
MgCl2, 10 mM DTT –pH 8.3-) at room temperature (RT) for 
60 min. RNase H was later inactivated by incubating at 65 ºC 
for 15 min. After applying the fragmentation protocol, endog-
enous levels of Fas isoforms were evaluated using the SPR 
biosensor. 
Isoform hybridization and biosensor regeneration. Splicing 
variants detection was performed by injection of the target 
splicing variant samples into the biosensors at a 15 µL/min 
rate and subsequent hybridization with their complementary 
DNA-probes immobilized on the sensor surface. These sam-
ples were dissolved in the hybridization buffer (3xSSC -0.45 
M in NaCl, 0.045 M sodium citrate- with a 45% formamide). 
Isoform-probe interactions were disrupted by using a 50% 
formamide in aqueous solution. Calibration curves were ob-
tained for each DNA probe by triplicate measurements of the 
DNA Fas gene AS isoforms synthetic standards at different 
concentrations (2.5, 5, 10, 20, 30, and 50 nM). The mean and 
the standard deviation (SD) of each concentration were plotted 
versus the target concentration and fitted to a curve. Frag-
mented and non-fragmented total RNA samples from HeLa 
cells were diluted in hybridization buffer to 20 ng/µL and ana-
lysed by SPR biosensor at the same conditions used for the 
standards. In addition, purified total RNA from bacteria (XLI 
Blue) was used as a negative control. 
 
 
Table 2.  DNA probes for RNase H cleavage and Fas mRNA 
fragments generated after the cleavage. 






























25 5’ TGCAAGGGTCACAGTGTTCACATAC 3’ 
Fas exon 
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Figure 2. Optimization of RNase H conditions for Fas gene alternative splicing analysis through SPR biosensor. (A) Scheme of the strate-
gy followed for the optimization of the RNase H activity by SPR analysis. (B) RNase H buffer concentration optimization. (C) RNase H 
concentration optimization. (D) Temperature optimization for RNase H activity optimization (RT: Room Temperature). 
 
Data analysis. The data were collected and analysed using 
Origin 8.0 software (OriginLab, Northampton, MA). Graph-
ical representation and calibration curve interpolation was 
performed in Graphpad prism 8 (Graphpad Software, San Di-
ego, CA -EEUU-) The experimental detection limit (LOD) 
was defined as the target concentration providing a ΔR (%) in 
the hybridization signal at least three times higher than that of 
the standard deviation of the control signal. The coefficients of 
variation were obtained as the ratio of the standard deviation 
to the mean, expressed in percentages (%CV). Agreement 
between RT-qPCR and SPR was assessed by applying the 
Bland-Altman model for replicate measurements. 
RESULTS AND DISCUSSION  
Specific RNA cleavage optimization.  
The assessment of the RNase H activity was carried out using 
a portable custom-designed SPR biosensor27. This SPR bio-
sensor is based on Kretschmann configuration and monitors 
refractive index changes at a fixed angle of incidence. It ena-
bles analysis in real time, offering the advantage of monitoring 
biological interactions as they happen.   
The biosensor response is represented in sensograms that re-
produce the binding event by monitoring the increase (binding 
events) or decrease (unbinding events) of the intensity of the 
reflected light (ΔReflectivity (%), ΔR (%)) vs. time (seconds, 
s). This change of the intensity of the reflected light is directly 
related to the mass changes on the gold surface, which corre-
spond to the concentration of the hybridized RNA. The light 
source is divided into two identical beams, generating a sur-
face plasmon in two different flow-cells of 300 nL each. This 
allows for parallel, independent analyses of two different sam-
ples. We took advantage of this process to assess and optimize 
RNase H activity exploring different parameters of the reac-
tion, including: (i) the reaction buffer concentration, (ii) the 
enzyme concentration, and (iii) the reaction temperature.  
We employed a short RNA sequence (RNA1) (Table 1) for the 
evaluation of the activity of the enzyme. We immobilized a 
specific complementary DNA probe (DNA1 probe Table 1) for 
the specific capture of RNA1 and, subsequently, monitored the 
RNA hybridization and RNase H activity in real time (Figure 
2A). A change in the refractive index will be observed during 
the specific hybridization of the complementary RNA1 target, 
which will be directly related to its concentration in the ana-
lysed sample. Then, the interaction will find its equilibrium 
state and will reach a plateau in the SPR sensor signal. The net 
change in the baseline, expressed as variation of reflectivity 
(ΔR (%)), will be directly proportional to the concentration of 
the hybridized target sequence. RNase H can be employed 
during the examination of RNA sequences in SPR biosensors 
for the regeneration of the sensor surface. The regeneration is 
underpinned by the RNase H-induced degradation of the RNA 
sequences previously hybridized to the immobilized DNA 
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probes, rendering them available for further analyses30. Thus, 
eventually, the hybridization will be interrupted by the RNase 
H solution, degrading RNA1 sequence, and returning the base-
line to its original level.  
First, we evaluated effect of the reaction buffer on RNase H 
activity. The buffer composition, pH, and ionic strength of the 
solution are known to influence enzymatic cleavage efficien-
cy. The optimum buffer composition for RNase H activity has 
been established and reported elsewhere (i.e., 50 mM Tris-
HCl, 75 mM KCl, 3 mM MgCl2, 10 mM DTT, pH 8.3)
19. 
However, the concentration of salts must be tested for specific 
applications. The study was carried out as depicted in Figure 
2A. 
A DNA1 probe was immobilized in-situ on the gold sensor 
chip and continuous 5x saline-sodium citrate (5x SSC) buffer 
at pH 7 was supplied over the functionalized sensor surface 
until a baseline was reached. Then, RNA1 was hybridized at a 
50 nM concentration in 5x SSC buffer with its specific recep-
tor attached to the biosensor surface. Once we reached the 
equilibrium of the interaction, we flowed 250 U/mL of the 
enzyme at different RNase H buffer concentrations (1x, 2x and 
3x) at RT (i.e. 25 ºC). The capability of the enzyme at each 
buffer concentration to return the sensor signal to the initial 
level due to the cleavage was evaluated. As can be observed in 
Figure 2B, the SPR signal dropped drastically below the initial 
baseline during the RNase H activity (RNase on). This dip in 
the signal was mainly caused by the difference in the RNase H 
buffer composition compared to the continuous buffer, pro-
ducing a drastic drop in the refractive index of the medium 
and obscuring the monitoring of the degradation process. After 
RNase H treatment, the sensor surface was washed again with 
the running buffer and the net change between the sensor sig-
nal at the equilibrium of interaction and the new baseline pro-
vided the approximate % of degraded RNA by the enzyme's 
activity. At a 2x buffer concentration, the baseline did not 
return to its initial level, indicating that only a 48% of the hy-
bridized RNA was degraded. A similar result was observed at 
3x buffer concentration. On the contrary, the baseline com-
pletely returned to the initial level at a 1x buffer concentration, 
confirming highest RNase H activity at this buffer concentra-
tion.  
Once 1x was established as the proper buffer concentration, 
we tested the optimal enzyme concentration needed for the 
reaction. We injected four different concentrations of RNase H 
enzyme: none, 1, 10, 50 and 100 U/mL. As depicted in Figure 
2C, the latter cleaved the hybridized RNA almost completely 
and achieved the same results as when using 250 U/mL while 
lower concentration failed in the full degradation of the RNA, 
indicating that a concentration of 100 U/mL of RNase H was 
sufficient to carry out the complete cleavage of the sequence. 
Finally, we explored the enzyme activity at different reaction 
temperatures. We tested room temperature (RT), 40 ºC and 50 
ºC by preheating the RNase H solution before flowing it in the 
SPR biosensor. At 40 ºC and 50 ºC, the enzyme was not fully 
effective, cleaving less than half of the hybridized RNA (Fig-
ure 2D). On the contrary, RT conditions achieved the best 
results, returning the sensor signal to the initial levels. Accord-
ing to these results, we considered that optimal conditions for 
RNase H activity were 100 U/mL enzyme concentration dilut-
ed in a 1x reaction buffer at RT. 
 
Comparative study of mRNA fragmentation procedures 
for Fas gene AS evaluation.  
The optimized procedure for specific mRNA fragmentation by 
the RNase H enzyme was applied and evaluated for selective 
biosensing of endogenous levels of Fas gene AS isoforms 
directly from HeLa cells samples. We also compared its per-
formance with non-fragmented and with alkaline-hydrolyzed 
samples.  
RNase H cleavage was performed off-sensor on purified RNA 
from HeLa cells to assess the expression levels of Fas gene 
mRNA isoforms by following the experimental procedure 
depicted in Figure 1. In order to obtain Fas gene isoform 
fragments of interest, we designed 25 nt DNA sequences com-
plementary to the sequences flanking exon 5 (3’ end of exon 
4) and exon 7 (5’ end of exon 8). These sequences, once hy-
bridized to the endogenously transcribed isoforms, should 
promote the degradation of the hybridized RNA sequence, 
producing fragments of approximately 200 nt (Table 2). For 
comparison, alkaline hydrolysis was performed in parallel as 
previously described16: RNA samples were preheated at 95 ºC 
for 15 s, mixed them with preheated 1x alkaline hydrolysis 
buffer and incubated the mix for 3.5 min (incubation time was 
previously optimized in order to obtain RNA fragments of an 
average of 200 nt) (Figure S2). 
 
Figure 3. SPR sensograms of the detection of 20 ng/µL of total 
HeLa cell RNA for the endogenous expression of both (A) 
Fas567 isoform and (B) Fas57 isoform after applying RNase H 
cleavage (H) (purple line), the alkaline hydrolysis (Δ) (orange 
line) and without any sample fragmentation (0) (green line). The 
grey line represents the signal given by the RNA control sample. 
Adapted from16 with permission of Elsevier. 
 
To stop RNA degradation, samples were placed on ice and 
mixed with sodium acetate (pH 5.2). The time of incubation is 
crucial and will strongly depend on the concentration and 
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quality of the samples. Lower RNA concentrations will be 
degraded faster, leading to shorter fragments for similar incu-
bation times. Likewise, poor-quality samples will already pre-
sent some level of degradation and could lead to sample input 
losses. Therefore, it should be carefully optimized in each 
case. 
After each fragmentation process, samples were diluted in the 
hybridization buffer to 20 ng/μL of purified total RNA.  In 
order to detect Fas gene AS isoforms through SPR, a clean 
gold sensor chip was activated and placed into the SPR device. 
Immobilization of Fas57 and Fas56 probes was carried out in 
independent microfluidic cells. Mixed SAMs of either Fas567 
or Fas57 probes and alkanethiol 6-mercapto-1-hexanol (MCH) 
at a ratio of 20:1 were prepared and flowed over two different 
SPR sensor channels. MCH is a commonly used backfiller that 
acts as a lateral spacer, improving the target accessibility by 
minimizing steric hindrance forces created between the DNA 
probes in densely packed monolayers.  After that, the mRNA 
samples obtained from HeLa cells after fragmentation are 
flowed over the functionalized sensor surface, and the specific 
Fas57 and Fas567 are captured and detected in real time. We 
monitored the SPR response recorded for each isoform in both 
SPR sensor channels. Results obtained using RNase H cleav-
age (SPRH) and alkaline hydrolysis protocol (SPRΔ) were 
compared with non-fragmented samples (SPR0). Figures 3A 
and B show the SPR responses obtained after injection of 
HeLa cell total RNA samples for each receptor. SPR sen-
sograms showed a significant increment of the sensor signal 
after sample injection time (≈ 100s) due to differences in the 
refractive index of the hybridization buffer. After sample in-
teraction, we washed the sensor surface with the continuous 
running buffer and analyzed the net changes in the baseline 
levels, which will correspond to the quantity of target hybrid-
ized to the biosensor. As can be seen in Figure 3, endogenous 
RNAs without any cleavage generated SPR responses of 
0.02% and 0.09% ΔR for Fas57 and Fas567, respectively. In 
contrast, samples treated with RNase H produced an ΔR of 
0.12% and 0.57% for Fas57 and Fas567, respectively. Alka-
line hydrolysed samples showed increments in the SPR reflec-
tivity of 0.09% (Fas57) and 0.49% (Fas567). Negative control 
RNA purified from bacteria produced negligible SPR sensor 
responses, returning to the baseline level and confirming the 
specificity of the detection. Therefore, the application of either 
of the fragmentation protocols resulted in an increment in the 
SPR sensor responses for both isoforms. These results confirm 
our hypothesis that RNA fragmentation increase the accessi-
bility of the target to the monolayer and, therefore, enhance 
the SPR detection response. 
 
Validation of the measurement results using RT-qPCR. 
In order to obtain quantitative data of Fas AS isoform levels, 
we carried out calibration curves using synthetic DNA stand-
ard sequences (Fas567 and Fas57 isoforms, Table 1) corre-
sponding to the exonic regions 567 and 57 of Fas gene AS 
isoforms (Figures 4A and 4B). These DNA sequences were 
designed with lengths of 150-200 nt to simulate the fragment 




Figure 4. Quantitative analysis of mRNA Fas gene isoforms by 
SPR. SPR calibration plots for Fas57 (A) (R2= 0.99) and Fas56 
(B) (R2=0.99) probes using the optimized hybridization and de-
tection conditions. Solid lines correspond to the non-linear fit of 
the calibration curves. Red dashed line corresponds to 3xSD SPR 
noise, which is the limit for the minimum signal detectable. All 
data show mean ± SD of triplicate measurements. (C) Histograms 
comparing the analytical quantification of Fas57 (left) and 
Fas567 (right) isoforms. (D) Histogram comparing the 567/57 
ratio after each condition tested by SPR. All data show mean ± 
SD of duplicate measurements. Figure A and B are reprinted 
from16 with permission of Elsevier. 
 
We analysed different concentrations (ranging from 0 to 50 
nM) for both sequences diluted in the hybridization buffer. By 
applying these conditions, we achieved limits of detection of 
387 and 438 pM for Fas57 and Fas567 isoforms, respectively. 
Such detection limits prove the excellent sensitivity of our 
methodology for the direct and label-free assay of nucleic 
acids, which is usually in the nM-pM range 31.  
SPR quantitative data was obtained by interpolation of the 
SPR response in the calibration curve equation specific for 
each isoform. Figure 4C shows the quantification of the two 
isoforms under each condition. Quantitative data obtained 
from non-fragmented samples (SPR0) were 24.6/5.5 nM for 
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Fas567/Fas57. In contrast, the quantities detected increased 
by a factor of ten after the application of either fragmentation 
protocol (262/12 nM for SPRΔ and 295/13.1 nM for SPRH).  
To validate the results and the methodology introduced in this 
work for site-specific mRNA cleavage, we carried out parallel 
analysis of HeLa RNA samples with RT-qPCR. Table 3 shows 
the comparison between the quantification performed by RT-
qPCR and the three different approaches carried out using the 
SPR biosensor. According to RT-qPCR data (365/20.3 nM), 
SPR results from non-fragmented samples heavily underesti-
mated RNA abundance (accuracy lower than 30%), confirm-
ing the need for a fragmentation process.  
RNase H cleavage results showed 81% accuracy for Fas567 
and 65% for Fas57 compared to RT-qPCR, whereas alkaline 
hydrolysis showed accuracies of 65% for Fas567 and 59% for 
Fas57. Thus, RNase H outperformed alkaline hydrolysis up to 
20% for the detection of the different isoforms, leveraging this 
approach for a more accurate detection of AS events. The 
slight underestimation of isoform concentrations by SPRH 
compared to the results from the RT-qPCR could be due to 
limitations in the sensitivity of the SPR biosensor, since anal-
yses are performed in an amplification-free and label-free 
scheme.  
Finally, to further confirm the advantages of the RNase H 
fragmentation, we applied the procedure to quantify Fas 
(567/57) isoform ratios in a highly accurate and selective 
manner (Figure 4D). Isoform ratio is a key feature to predict 
the aberrant regulation of AS events. Therefore, it is the most 
important parameter in order to test the efficiency of AS event 
analysis. As can be appreciated in the figure, the ratio between 
isoforms is very different in the absence of fragmentation.  
According to SPRH results, Fas567 isoform had increased 
expression compared to Fas57 isoform, leading to an isoform 
ratio (567/57) of 22.0 ± 0.7. These results show a good corre-
lation with the RT-qPCR (567/57 =17.9 ± 0.4). Also, in order 
to test the agreement between the two techniques, different 
RNA samples presenting different isoform ratios were ana-
lysed and compared by SPRH and RT-qPCR. To induce differ-
ent isoform ratios, HeLa cells were transfected with a 
minigene expressing Fas genomic sequences. Then, total RNA 
was purified either alone or co-transfected with a vector ex-
pressing the Polypyrimidine-Tract-Binding protein (PTB). 
PTB induces skipping of Fas exon 6 acting through an exonic 
silencer sequence29. While expression of the minigene alone 
leads to preferential accumulation of exon 6-including tran-
scripts, co-expression of Fas567 minigene with PTB leads to 
higher accumulation of transcripts that skip exon 628. Each 
condition was analysed by SPRH and RT-qPCR and isoform 
ratios were calculated. All samples tested (6/6) were found 
within the limits of agreement (Figure S3). In fact, the agree-
ment between SPR measurements and RT-PCR is higher for 
RNase H digestion compared to alkaline hydrolysis performed 
in our previous work by a 20% (83% agreement), confirming 
that RNase H cleavage is a more accurate approach for the 







Table 3.  RT-qPCR and SPR comparison of the isoform content 
analysis from HeLa cells endogenous expression. Isoform concen-
tration in nM for SPR was calculated through the calibration 




Concentration (nM)  
RT-qPCR* SPR* Fragmentation 
567 365 ± 17
a
 
24.6 ± 0.40 No fragmentation 
262 ± 27 Alkaline hydrolisis 
295 ± 14 RNaseH cleavage 
57 20.3 ± 0.4
a
 
5.5 ± 0.1 No fragmentation 
12.0 ± 0.8 Alkaline hydrolisis 
13.1 ± 0.3 RNaseH cleavage 
*Mean ± SD of endogenous concentration of HeLa cell’s total 
RNA calculated from 2 different samples in each experiment. 
 
CONCLUSION 
Alternative splicing can contribute to the development and 
progression of human malignancies and it has been highlight-
ed as a hallmark of cancer. The use of alternatively spliced 
isoforms as biomarkers will likely increase in the near future. 
Evaluating the impact of AS variants in cancer could be 
adopted as an integral part of clinical diagnosis. In addition, 
modulation of isoform ratios poses great promise in future 
precision medicine for personalized therapies.  
Despite the significant advances in optical biosensors and their 
potential application for rapid diagnostics tests, there is a lack 
of applications related to long RNA sequences, such as mRNA 
isoforms, due to the difficult access of these sequences to their 
specific DNA-probes in the biosensor bioreceptor monolayer. 
We show that this biosensing approach can be greatly en-
hanced by previous sample pre-processing steps to generate 
targets with the desired length that will not display the limita-
tions associated to long RNAs. 
We have adopted a methodology for the site-specific cleavage 
of mRNA sequences in order to obtain fragments with a pre-
cise sequence and length of interest. It has been employed for 
the fast and direct monitoring of alternative splicing events in 
real-time using an SPR biosensor. Our methodology involves 
the design of specific DNA oligonucleotides that hybridize the 
flanking segments of the RNA fragment of interest, promoting 
their degradation by RNase H activity. This approach permits 
the generation of mRNA fragments with the appropriate length 
with high selectivity, ensuring their accurate quantification via 
optical biosensors. 
The feasibility of the methodology was tested in complex 
RNA mixtures purified from HeLa cells expressing endoge-
nous Fas gene mRNA transcripts. The results strongly corre-
lated with RT-qPCR data, with a detection accuracy up to 
81%. In addition, they showed higher correlation between the 
RNase H cleavage and RT-qPCR compared with the conven-
tional fragmentation process based on alkaline hydrolysis by a 
20%. These results confirm that site-specific RNA fragmenta-
tion reduces errors in isoform quantification, probably due to a 
lower loss of sample input than when applying random frag-
mentation. A slight underestimation of the isoform concentra-
tions was observed in the SPR analysis, which could be prob-
ably due to limitations in the sensor sensitivity. One solution 
could be the implementation of this methodology in other la-
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bel-free optical biosensors. For example, bimodal waveguide 
interferometers (BiMW) have demonstrated to outperform 
SPR sensitivities up to three orders of magnitude in the detec-
tion of AS events32.  
Our methodology, along with the label-free detection and the 
minimized sample manipulation, provides an advance in the 
real-time monitoring of AS events. In our view, these results 
open the door for the routine use of alternatively spliced 
isoforms as biomarkers for diagnosis and patient follow-ups 
during therapy. In addition, it tackles the challenges encoun-
tered in the analysis of long RNA sequences with label-free 
optical biosensors, enabling to exploit the potential of these 
biosensors for highly sensitive, selective, fast and user-
friendly genomic and epigenomic analyses. Moreover, it can 
be implemented in more integrated and sensitive platforms 
that allow for multiplexed analysis of multiple AS events 32.  
This work provides a significant step forward for the devel-
opment of sensitive diagnostic tools based on nucleic acid 
biomarker detection for cancer research. 
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